tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Income Statement

Compare
532 Followers

Supernus Pharmaceuticals Income Statement

Last quarter (Q3 2025), Supernus Pharmaceuticals's total revenue was $192.10M, an increase of 9.34% from the same quarter last year. In Q3, Supernus Pharmaceuticals's net income was $-45.12M. See Supernus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 661.82M$ 607.52M$ 667.24M$ 579.77M$ 520.40M
Gross Profit
$ 583.91M$ 523.74M$ 580.02M$ 504.71M$ 467.94M
Operating Expenses
$ 502.25M$ 529.01M$ 533.89M$ 418.69M$ 294.24M
Depreciation and Amortization
$ 80.41M$ 84.86M$ 85.54M$ 32.59M$ 18.14M
EBITDA
$ 178.28M$ 90.04M$ 153.36M$ 129.19M$ 210.54M
Operating Income
$ 81.67M$ -5.27M$ 46.12M$ 86.03M$ 173.70M
Other Income/Expenses
$ 16.20M$ 8.04M$ 14.62M$ -12.85M$ -5.05M
Pretax Income
$ 97.87M$ 2.77M$ 60.74M$ 73.17M$ 168.65M
Net Income
$ 73.86M$ 1.32M$ 60.71M$ 53.42M$ 126.95M
Per Share Metrics
Basic EPS
$ 1.34$ 0.02$ 1.13$ 1.01$ 2.41
Diluted EPS
$ 1.32$ 0.02$ 1.04$ 0.98$ 2.36
Weighted Average Shares Outstanding
55.10M 54.54M 53.67M 53.10M 52.62M
Weighted Average Shares Outstanding (Diluted)
55.96M 55.51M 61.68M 54.36M 53.69M
Currency in USD

Supernus Pharmaceuticals Earnings and Revenue History